FacebookTwitterGoogle+RedditEmail

The Komen Con

by DOUGLAS A. BERG

Nancy Goodman Brinker, a pioneer of “cause marketing”, founded Susan G. Komen For the Cure in 1982, reportedly as the fulfillment of a deathbed promise made to her sister, a victim of breast cancer. In 1994, Brinker founded In Your Corner, Inc., a for-profit company that markets health products and information. In 1998, Brinker sold In Your Corner to AstraZeneca, the third largest pesticide manufacturer in the world, primarily through Syngenta, a giant global agribusiness company it owns jointly with Novartis.

AstraZeneca has had close ties to Brinker for many years. It gave $97,000 to Komen and its affiliates in the first 6 months of 2008 alone, and it has been a big presence at Komen’s Race for the Cure. AstraZeneca is also one of the largest contributors to Breast Cancer Awareness Month.

The problem here is that pesticides cause breast cancer.

AstraZeneca solves the problem by no longer advertising itself as a pesticide manufacturer.  It is a “life-sciences” company. Ta da! Problem solved! Well, they still manufacture more pesticides than ever (substances that congregate in the sexual glands of mammals causing cancers, birth defects, etc., etc.,) but “life sciences” sounds so reassuring, yes?

Susan G. Komen has created a lengthy list of risk factors for breast cancer.  Nowhere in this list can you find exposure to toxins, probably the greatest risk factor of all.

Hey Nancy! Didn’t your sister ask you to cure breast cancer? Was her dying wish, “Please forgive them for killing me, pay yourself half a million dollars a year – and oh by the way please protect those poor pesticide manufacturers. They know not what they do.”

It gets worse. You’ve heard the famous slogan “The best prevention is early detection.” Think about it: If you get breast cancer, you didn’t see the doctor soon enough. Your fault. Next case.

No wonder AstraZeneca gives handsomely. The focus of Komen and pharmaceutical research is entirely on screening and treatment, not on prevention. In other words, “the cure” focuses on the symptoms and ignores the cause. Less than 5% of the total research dollars in this country are spent determining and eliminating the causes of cancer — none of that money, you can bet, spent by “life sciences” companies.

You have to hand it to AstraZeneca. Not only do they recognize and reward good propaganda when they see it, they also recognize a great market opportunity. Since the 90’s, AstraZeneca has bought up cancer treatment centers until it owns one of the country’s largest chains. With $13 billion in profits in 2011, it makes billions on oncology drugs, and it makes billions on pesticides and herbicides.

In business parlance, this is “vertical integration.” AstraZeneca causes cancer, they give money to charities that ignore the causes of cancer, and they “cure” us with their toxic drugs. An enviable business model–the worse the product, the more money they make.

And AstraZeneca isn’t the only culprit in this unholy alliance. General Electric is also a large contributor to Susan G. Komen. Mammograms have come under heavy criticism in recent years for needlessly exposing patients to radiation, and for yielding numerous false positives which often result in unnecessary surgeries. Unlike many doctors and charities, Komen continues to recommend annual mammograms. GE, not so coincidentally, is a huge manufacturer of mammogram equipment. Europe has a only fraction of the breast surgeries that occur in the U.S., and yet they have nearly identical rates of cancer deaths.

It is hard not to think of Komen as a pure propaganda ploy, and a great tool for supplying qualified prospects to the cancer industry. Is it any surprise that Nancy Brinker was a bundler of campaign contributions for George W. Bush and also a Bush Pioneer, a title that required making contributions of at least $100,000 to his Presidential Campaign? Is it surprising that the staff of Komen is stuffed full of right-wing extremists? Anyone surprised by Komen’s decision to drop Planned Parenthood?

If you are surprised, you’ve bought Susan G. Komen’s purported mission of “curing” breast cancer, rather than understanding the real mission of the cancer-industry and its supporters in the “life science” of killing insects with chemicals that also kill humans. Putting the spotlight upon this unholy alliance is making some very rich, very immoral people very nervous.

Expect a rash of corporate name changes and massive increases in public relations budgets if the attention lasts much longer. What one should not expect is any change in business practices.

Douglas A. Berg is a computer scientist and children’s book writer in Mesa, Arizona. He contributed this article to ThisCantBeHappening!, the new independent Project Censored Award-winning online alternative newspaper, which is available at www.thiscantbehappening.net

 

 

 

 

 

 

 

 

 

 

More articles by:

CounterPunch Magazine

minimag-edit

bernie-the-sandernistas-cover-344x550

zen economics

May 24, 2017
Paul Street
Beyond Neoliberal Identity Politics
Daniel Read
Powder Keg: Manchester Terror Attack Could Lead to Yet Another Resurgence in Nationalist Hate
Robert Fisk
When Peace is a Commodity: Trump in the Middle East
Kenneth Surin
The UK’s Epochal Election
Jeff Berg
Lessons From a Modern Greek Tragedy
Steve Cooper
A Concrete Agenda for Progressives
Michael McKinley
Australia-as-Concierge: the Need for a Change of Occupation
William Hawes
Where Are Your Minds? An Open Letter to Thomas de Maiziere and the CDU
Steve Early
“Corporate Free” Candidates Move Up
Fariborz Saremi
Presidential Elections in Iran and the Outcomes
Dan Bacher
The Dark Heart of California’s Water Politics
Alessandra Bajec
Never Ending Injustice for Pinar Selek
Rob Seimetz
Death By Demigod
Jesse Jackson
Venezuela Needs Helping Hand, Not a Hammer Blow 
Binoy Kampmark
Return to Realpolitik: Trump in Saudi Arabia
Vern Loomis
The NRA: the Dragon in Our Midst
May 23, 2017
John Wight
Manchester Attacks: What Price Hypocrisy?
Patrick Cockburn
A Gathering of Autocrats: Trump Puts US on Sunni Muslim Side of Bitter Sectarian War with Shias
Shamus Cooke
Can Trump Salvage His Presidency in Syria’s War?
Thomas S. Harrington
“Risk”: a Sad Comedown for Laura Poitras
Josh White
Towards the Corbyn Doctrine
Mike Whitney
Rosenstein and Mueller: the Regime Change Tag-Team
Jan Oberg
Trump in Riyadh: an Arab NATO Against Syria and Iran
Susan Babbitt
The Most Dangerous Spy You’ve Never Heard Of: Ana Belén Montes
Rannie Amiri
Al-Awamiya: City of Resistance
Dimitris Konstantakopoulos
The European Left and the Greek Tragedy
Laura Leigh
This Land is Your Land, Except If You’re a Wild Horse Advocate
Hervé Kempf
Macron, Old World President
Michael J. Sainato
Devos Takes Out Her Hatchet
L. Ali Khan
I’m a Human and I’m a Cartoon
May 22, 2017
Diana Johnstone
All Power to the Banks! The Winners-Take-All Regime of Emmanuel Macron
Robert Fisk
Hypocrisy and Condescension: Trump’s Speech to the Middle East
John Grant
Jeff Sessions, Jesus Christ and the Return of Reefer Madness
Nozomi Hayase
Trump and the Resurgence of Colonial Racism
Rev. William Alberts
The Normalizing of Authoritarianism in America
Frank Stricker
Getting Full Employment: the Fake Way and the Right Way 
Jamie Davidson
Red Terror: Anti-Corbynism and Double Standards
Binoy Kampmark
Julian Assange, Sweden, and Continuing Battles
Robert Jensen
Beyond Liberal Pieties: the Radical Challenge for Journalism
Patrick Cockburn
Trump’s Extravagant Saudi Trip Distracts from His Crisis at Home
Angie Beeman
Gig Economy or Odd Jobs: What May Seem Trendy to Privileged City Dwellers and Suburbanites is as Old as Poverty
Colin Todhunter
The Public Or The Agrochemical Industry: Who Does The European Chemicals Agency Serve?
Jerrod A. Laber
Somalia’s Worsening Drought: Blowback From US Policy
Michael J. Sainato
Police Claimed Black Man Who Died in Custody Was Faking It
Clancy Sigal
I’m a Trump Guy, So What?
FacebookTwitterGoogle+RedditEmail